Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease

Completed · Phase 4

Conditions studied: Parkinson's Disease, Psychoses

In brief

The purpose of this clinical research study is to assess the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.

Key facts

Study ID

NCT00095810

Run by

Otsuka Pharmaceutical Development & Commercialization, Inc.

People needed

50

Starts

2003-07-01

Expected to finish

2004-09-01

Last updated by the study team

2013-11-08

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Primary diagnosis of idiopathic Parkinson's disease.
• Psychosis related to Parkinson's disease.

You may not qualify if…

• Psychosis present prior to diagnosis of Parkinson's disease.

Where it is running

• Local Institution — Albany, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.